ライフサイエンスコーパス: day post

1 EGD performed 2+/-1 days post ablation demonstrated superficial thermal lesi

2 patients with recurrence </=30 days and >30 days post ablation, respectively.

3 biomarkers were analyzed during the first 60 days post admission.

4 Our outcome measure was 30 day post-admission survival.

5 Analyses done both at 120 and 180 days post-AlloHCT showed that the EB-BSI density increas

6 considered patients who survived at least 30 days post-AMI (full sample), or who survived for 1 year

7 101a expression is rapidly depleted within 3 days post-amputation (dpa) but is highly upregulated by

8 elated with higher lignin content at 25 DPA (Days Post Anthesis).

9 hat the promoter is particularly active at 7 days post anthesis.

10 ts fuzzless-lintless (fl) mutant at -3 and 0 day post-anthesis.

11 uit were assessed throughout ripening (30-50 days post-anthesis; dpa) in grafted and self-rooted plan

12 comes were 90-day survival, clinical cure 14 days post antibiotic cessation, alive organ failure-free

13 ke to M2-like phenotype within a mean of 3.5 days post antibiotics treatment, which is dependent on b

14 lite cell content increased 80% (P < 0.05) 2 days post-B1 (P < 0.05), remained elevated 27 days post-

15 .1 +/- 0.4-fold (P < 0.05), respectively, 27 days post-B1 and were unaffected by B2.

16 ays post-B1 (P < 0.05), remained elevated 27 days post-B1, and was unaffected by B2.

17 thylated, achieving adult-like status by 3-6 days post birth.

18 l lineages, including T cells, for up to 335 days post-BMT.

19 dorsal muscles were studied at 7, 14 and 21 days post-burn.

20 At 30 days post-CABG, 544 (68.4%) patients received DAPT and 2

21 Seven days post-CBD, blood gases and ventilation in 21% O2 wer

22 hanical allodynia and thermal hyperalgesia 1 day post-CFA injection.

23 usage, EBOTAb was first delivered 1, 2 or 3 days post-challenge with a lethal dose of EBOV.

24 macaques when treatment is initiated up to 5 days post-challenge.

25 eived siRNA-LNP beginning at 1, 2, 3, 4 or 5 days post-challenge.

26 Lhx3/Lhx4 expression in RP epithelium at 9.0 days post coitum (dpc) and total loss of pituitary tissu

27 Injection of PAF or SP-A into AF at 17.5 days post coitum enhanced uterine NF-kappaB activation a

28 At 3.5 days post-coitum (dpc) and 4.5 dpc, the tetraploid ESCs

29 d in the developing heart at E10.5 and E11.5 days post-coitum and in the musculoskeletal system from

30 e musculoskeletal system from E13.5 to E15.5 days post-coitum, where it was co-localized with hyaluro

31 ygote embryos occurred between 14.5 and 16.5 days post-coitus.

32 ibed mice null for Col5a1, which die at 10.5 days post conception and virtually lack collagen fibrils

33 sity is embryonic lethal at approximately 12 days post conception.

34 onic progenitors enter lung buds before 13.5 days post-conception, expand, and form an extensive line

35 man fetal cortex samples, spanning 23 to 184 days post-conception, indicates that schizophrenia-assoc

36 hospital stay was significantly reduced (4.6 days post-CPG vs 5.1 days pre-CPG, P < .05).

37 analyzed motoneurons during regeneration (21 days post crush) and after they reinnervate muscle (3 mo

38 eline within 24-72 hours of exposure--and 30-day post-CT emergent dialysis and death were determined

39 ight(3%) of whom were discharged prior to 28-days post decision to intervene surgically.

40 ts who died and 232 patients who survived 30-day post discharge were 0.03 (0.04-0.21) and 0.17 (0.08-

41 likelihood of outpatient follow-up within 30 days post discharge (risk-adjusted incidence, 69.9% vers

42 likely to be readmitted within the first 30 days post discharge compared with direct-arrival patient

43 Secondary analysis of initial 30 days post discharge showed effect modification by venue

44 There were no changes in trends for 30-day post-discharge care for MI or pneumonia; however, th

45 Of 1,591 Medicare Part D patients, 90-day post-discharge warfarin persistence among patients d

46 07 to 2012 (n=158 795) were followed for 182 days post-discharge to identify discontinuation, defined

47 during the index hospitalization or within 7 days post-discharge).

48 had bleeds and 991 had MIs between 7 and 365 days post-discharge.

49 with an increased likelihood of death at 30 days post-discharge.

50 for early (1 to 60 days) and late (61 to 365 days) post-discharge time periods.

51 of 300 days (interquartile range: 130 to 509 days) post-discharge.

52 by a statin fill, was identified in the 365 days post-discontinuation.

53 as generally safe and immunogenic through 28 days post-dose 4 in adults with STM, HM, and HIV.

54 ZV-specific immune response approximately 28 days post-dose 4, measured by gpELISA (estimated geometr

55 V-specific immune responses approximately 28 days post-dose 4, measured by gpELISA and IFN-gamma ELIS

56 ety and tolerability was assessed through 28 days post-dose 4.

57 d by gpELISA or ELISPOT, at approximately 28 days post-dose 4.

58 ctively restore memory at all ages, from one-day post-eclosion to thirty-day-old flies, proving their

59 At 7 days post-ethanol exposure, we observed increased sponta

60 sed anxiety-like behavior at both 24 h and 7 days post-ethanol exposure.

61 p to 72 h, and mortality was monitored for 7 days post exposure.

62 of Ag and for biological responses up to 56 days post-exposure (8 weeks).

63 We recorded mortality rates 6 days post-exposure, and the behavioral response to pyret

64 ent WNV vector, capable of transmission at 5 days post-exposure.

65 ca, and lung injury was assessed 1, 3, or 14 days post-exposure.

66 etectable plasma viremia in all animals by 2 days post-exposure; virus replication kinetics are simil

67 resistant Staphylococcus aureus (MRSA) for 9 days post-feeding.

68 pment across 18 time points from 1 cell to 5 days post-fertilisation sampling individual and pools of

69 ed, axenic, and axenic larvae colonized at 1 day post fertilization (dpf) were evaluated using a stan

70 ntinued to exhibit abnormal behavior upto 12 days post fertilization due to changes in HTRs.

71 We exposed individuals (0 to 4 days post fertilization) of known genotypic sex to fluct

72 rlapping NOX isoform expression at 1 and 1.5 days post fertilization.

73 s, locomotion defects and death at around 10 days post fertilization.

74 atching rate and produced larger larvae at 5 days post fertilization.

75 show that when injected into the yolk of a 2 day-post-fertilization (dpf) embryo of Tg (fli1:EGFP or

76 pendent feeding under European law (from 5.2 days post-fertilization (dpf) at 28.5 degrees C).

77 ish had reduced lck:GFP+ thymic T cells by 5 days post-fertilization that persisted into adult stages

78 lipid accumulation was already detected at 5 days post-fertilization with accompanying microglial act

79 sh model for ACR neurotoxicity by exposing 5 days post-fertilization zebrafish larvae to 1 mM ACR for

80 In zebrafish larvae (4 days post-fertilization), gene knockdown of either CBS o

81 Three days post-fertilization, GFP began expressing in distinc

82 n of a larval zebrafish (Danio rerio) at 5.5 days post-fertilization.

83 duced median survival with death occurring 5 days post-fertilization.

84 ents with bacterial meningitis on the fourth day post fever.

85 Deer were euthanized at 95, 105, 120 and 175 days post final inoculation and tissues examined for CWD

86 y recovered its carbon uptake capacity 30-60 days post fire.

87 sotalol, dronedarone, or Class Ic) within 14 days post-first AF encounter.

88 F1 generation were exposed to EDCs until 21 days post hatch (dph), reared to adulthood in clean wate

89 eawater succumbed to epitheliocystis from 21 days post hatching, causing mortality in a quarter of th

90 After a median of 285 days post-HCT, patients with PV-Haufen had an increased

91 rine samples were obtained at a median of 88 days post-HCT.

92 The main outcome was 90-day post hospital discharge all-cause mortality.

93 h enhanced inflammation, oxidative stress (1 day post-I/R), hypertrophy, and interstitial fibrosis (1

94 After an initial increase in TIMP4 (1 day post-I/R), TIMP4 mRNA and protein decreased in the i

95 nt mice, promoting neovascularization (at 28 days, post-I-R) and lower interstitial fibrosis, leading

96 The 7-day post-ICU FIM was predicted by age and ICU length of

97 The 7-day post-ICU Functional Independence Measure (FIM) deter

98 patients at the late convalescent phase (30 days post-illness).

99 the tears of infected patients for up to 30 days post-illness, and may therefore possess a potential

100 At 56 days post-immunisation, we found that rats with vasculit

101 mor growth inhibition, which lasted for >100 days post implantation of the tumor cells in mice.

102 The ECoG grid was explanted 28 days post-implantation with no adverse effect.

103 tients, 60% did not have a pharmacy claim 45 days post-index; by 2 years, this reduced to 20%.

104 noculation, ZIKV RNA is detected in plasma 1 day post infection (d.p.i.) in all animals (N=8, includi

105 Serum samples were collected at 7, 14 and 21 day post infection (DPI) from infected and control mice

106 ion levels of host immune-related genes at 1 day post infection (dpi) were higher in H5N8-infected th

107 influenza A virus at 0, 6, 10, 14, 21 and 28 days post infection (dpi), representing the major stages

108 DCs isolated from draining lymph nodes at 2 days post infection (dpi).

109 TGFbeta), Wnt and Notch pathways on 12 or 34 days post infection formed monolayers in vitro, and unde

110 tal challenge (day 0) and at 4, 7, 11 and 14 days post infection from 44 pigs revealed 6,430 differen

111 t shift towards stromal staining at peak (12 days post infection) hyperplasia, whereas staining for L

112 ated genes, such as Irf7 and Cxcl9; 7 and 60 days post infection, acquired immunity-related genes, su

113 g to the separation were as follows: 4 and 7 days post infection, innate immunity-related genes, such

114 rine encephalomyelitis virus on 4, 7, and 60 days post infection, we conducted bioinformatics analyse

115 curred only from donor hosts between 3 and 9 days post infection.

116 s clearly between the groups of 4, 7, and 60 days post infection.

117 R8/34 H1N1 and were followed up for up to 21 days post infection.

118 ine specimens from inoculated bats from 5-19 days post infection.

119 and did not affect viral contents at 4 and 8 days post infection.

120 e results observed for neutralization at one day post-infection showed MDCK cells were similar (<1 lo

121 e antisera per animal, at 30 minutes, 1 or 2 days post-infection (dpi), in which all animals survived

122 duction of neoplastic lesions in vitro at 27 days post-infection (PI), providing new evidence of the

123 cells become committed to a B-blast fate <12 days post-infection and are unable to de-repress p18INK4

124 levels of gene expression were detected at 3 days post-infection and increased over time, suggesting

125 these were not statistically different at 18 days post-infection compared to uninfected animals indic

126 ild-type (WT) and Tetherin KO mice at 3 to 7 days post-infection despite removal of a potent restrict

127 ns were sampled and cultured at 6, 13 and 20 days post-infection from the 4 groups.

128 ealed peak infection density in gut at 10-12 days post-infection when blood viral loads were low.

129 acute vs. early chronic infection (7 vs. 28 days post-infection), using neurological and behavioral

130 nfection when treatments were initiated nine days post-infection, a time when animals were demonstrat

131 6 spores unable to transmit malaria within 5 days post-infection, surpassing the World Health Organiz

132 cells were not readily detectable by ET at 5-days post-infection, whereas HIV-1-infected cells surrou

133 erified by amphetamine-stimulated rotation 7 days post-infusion.

134 nt at a prevalence of >25% until at least 14 days post initiation of treatment.

135 e cells arrive at the glomerular layer after day post injection (DPI) 7.

136 as very long with still 66% remained on 12th day post injection.

137 Spleen samples were collected at 40 days post injection (dpi), and sequenced.

138 fant, upper air way infection was observed 2 days post injection of the second eye.

139 s (43%) achieved adhesion release at mean 10 days post injection.

140 s necessitating euthanasia of all mice by 15 days post injection.

141 Although beta cell mass was preserved 8 days post-injection, total insulin content and insulin:c

142 injection on the same day, between 1 and 14 days post-injection.

143 of each conjugate per mouse) at 1, 7 and 13 days post-injection.

144 were efficiently cleared from the host by 20 days post-injection.

145 ary objective was safety and tolerability 28 days post-injection.

146 oxorubicin followed by LSFI at 3, 30, and 60 days post-injection.

147 oved locomotor function at 7, 14, 21, and 28 days post injury (DPI), when compared to control groups

148 lted in significantly higher R1 at 15 and 30 days post injury compared with WT mice that showed re-en

149 Overall miRNA expression at 1 and 3 days post injury strongly correlates with outcome measur

150 re evaluated at different time points for 14 days post injury whereupon animals were killed and cereb

151 lected before injury and then at 1, 3, and 5 days post injury.

152 tive function at various acute/subacute (1-7 day post-injury) and chronic (14-60 days post-injury) ti

153 At 1-day post-injury, concussed athletes with lower levels of

154 sma at 6 hours post-injury and in liver at 1 day post-injury, followed by gradual diminution over tim

155 As early as six days post-injury and without prior training of the monke

156 I (MULTI) groups and sacrificed at 21 and 35 days post-injury for analysis of healing fractures by mi

157 ry cortex of microglia-depleted animals at 7 days post-injury remained unchanged compared to contrala

158 ase in angiotensin II AT1 receptor mRNA at 3 days post-injury was also observed.

159 lites were assessed in concussed (N=18; 1.61 days post-injury) and healthy football players (N=18).

160 ute (1-7 day post-injury) and chronic (14-60 days post-injury) time points were examined.

161 t of trabecular bone in MULTI calluses at 21 days post-injury.

162 sion, was observed in medial layers of VSM 7 days post-injury.

163 when compared to calluses from FX mice at 21 days post-injury.

164 nd blood collections were conducted up to 30 days post-injury.

165 cerebral blood flow, when determined 1 to 3 days post-injury.

166 e were collected at 30, 60, 90, 105, and 120 days post inoculation (dpi) or at the onset of clinical

167 VA)-sensitized during the acute infection (3-days post inoculation) and then chronically underwent ch

168 Additionally, feces were collected for seven days post-inoculation to determine the effect on gut bac

169 ralis mixed with S. intermedius (P < 10-6) 7 days post-inoculation.

170 initial 24 h and increase between 24 h and 7 days post-IR, indicating a significant RBR in BM-EPCs in

171 calizes with ubiquitinated protein at the 30 days post irradiation time-point.

172 for 8 weeks prior to radiation as well as 30 days post irradiation.

173 olved in cognitive function, both 36h and 30 days post irradiation.

174 rological performance were assessed up to 28 days post-ischemia.

175 ient label to remain detectable for up to 10 days post-labeling both in vitro and in vivo in an immun

176 noninvoluted ducts were still present at 30 days post lactation, with a greater number of residual E

177 At 3 days post lactational involution, the mammary glands of

178 s and macrophages to CNV lesions at 1- and 3-days post laser injury, respectively.

179 actional shortening (-Delta11%; P<0.05) at 7 days post left anterior descending artery occlusion/repe

180 ve exhibited thromboembolism after 842+/-338 days post ligation.

181 Mice were sacrificed at 5, 9, 14, 28, and 56 days post-loading and whole knee joint changes were asse

182 nas invaded the host microbiota within three days post-LT, in association with a reduction in richnes

183 ients, respectively, at median 12.5 and 13.5 days post-LTx.

184 There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury.

185 alities, some of which were still present 30 days post-mFPI.

186 ll-cause or cardiovascular readmission at 30 days post MI between transferred-in and direct-arrival p

187 Myocardial hemorrhage 2 days post MI was associated with clinical characteristic

188 DC migration into the infarcted myocardium 5 days post MI, which was inhibited by ACK2.

189 ransactivator compared with wild-type mice 3 days post MI.

190 ctivator mice compared with wild-type mice 5 days post MI.

191 deling, increased by >60% from baseline at 5 days post-MI and by >100% at 21 days post-MI in the Ad-G

192 rved a linear relationship between T (req) 2 days post-MI and global longitudinal strain 6 months lat

193 aseline at 5 days post-MI and by >100% at 21 days post-MI in the Ad-GFP only group.

194 Seven days post-MI, LV function and parameters of LV remodelin

195 -related events composite endpoint within 30 days post-MRI.

196 tility as assessed by echocardiography at 14 days post myocardial infarction.

197 At 28 days post-myocardial infarction, exosomes derived from n

198 s and altered pattern of HSPC mobilisation 8 days post-myocardial infarction, with increased circulat

199 er noise exposure in the Foxo3KO/KO fourteen days post noise (DPN).

200 d these changes were observed as little as 2 days post-op.

201 .3 +/- 3 years, 64 (9%) patients died (0% 30-day post-operative deaths).

202 Studies reporting the primary endpoint, 30-day post-operative stroke rate, were included in a Bayes

203 ressures, prolonged chest tube drainage (>21 days), post-operative ventricular arrhythmias, renal ins

204 primary outcome was VTE occurring within 30 days post-operatively.

205 dministered at baseline and at 2 days and 90 days post-operatively.

206 hienopyridine) and aspirin monotherapy at 30 days post-operatively.

207 e 60 muL serum aliquots of blood collected 4 days post-oral exposure.

208 , the virus was present in saliva within two days post-oral infection.

209 dies in human embryonic and fetal stages (35 days post-ovulation to 9 weeks post-conception).

210 aths occurring during pregnancy and up to 42 days post partum were defined as pregnancy related.

211 to women who received Tdap vaccine within 14 days post partum.

212 spermine than spermidine, except for the 5th day post-partum.

213 eaching levels up to 4.41 mumol/l on the 3rd day post-partum.

214 cted at the 1st, 2nd, 3rd, 4th, 5th and 15th day post-partum.

215 m and all-cause neonatal mortality within 28 days post-partum among babies who survived the first 24

216 were all-cause neonatal mortality within 28 days post-partum and all-cause neonatal mortality within

217 in in the catchment area for follow-up of 28 days post-partum.

218 Between 60 days post-PCI and end of follow-up (median 24 months), 4

219 Tests were performed at 2 to 4 days and 30 days post-PCI.

220 RP and platelet reactivity were noted at 30 days post-PCI.

221 randomization, as well as prior to and >/=90 days post-placement in the LVAD group.

222 Mouse islets obtained 7 days post-Ppx displayed significantly increased c-Met, s

223 eta-cell replication compared with WT mice 7 days post-Ppx.

224 d insulin secretion compared with WT mice 28 days post-Ppx.

225 t cardiovascular magnetic resonance at 4+/-2 days post primary percutaneous coronary intervention, of

226 y subset at all time points tested, up to 30 days post-primary infection, suggesting a delay in the g

227 C locations ablated had VT recurrence at 605 days post procedure.

228 ore Lariat closure and after a minimum of 30 days post procedure.

229 observed hospital mortality was 7.2%, and 30-day post-procedure mortality was 8.5%.

230 However, 30-day post-procedure pacemaker insertion increased from 8.

231 erall stroke rate was 1.4% through the first day post-procedure, 3.0% at 30 days, and 5.6% at 2 years

232 .5 +/- 13.2 mm Hg to 7.2 +/- 2.8 mm Hg at 30 days post-procedure (p < 0.001).

233 SSIs within 90 days post-procedure were identified; infections during a

234 arin for ischemic stroke prevention or SE >7 days' post-procedure.

235 yA-immunized mice were 1,000-fold lower at 2 days post-RacL11 challenge than virus titers in the lung

236 talization, coronary revascularization >/=30 days post-randomization) during a median 6-year follow-u

237 re no procedure-related adverse events at 30 days post retrieval procedure.

238 etrovirally labeled new granule cells at 7-8 days post retroviral injection (dpi) show that these cel

239 At 30-days post-revascularization, for ACS patients the odds r

240 carriage is measured in a treated group, 14 days post-Salmonella challenge.

241 e CA1 area that reached minimal levels at 14 days post-SE and partially increased thereafter.

242 ominently altered at 12-hours post-SE; at 10-days post-SE, marked changes in metabolic and homeostati

243 accumulation occurred in the CA1 area at 14 days post-SE.

244 The early transient (3 days) post-SE infusion of bumetanide reduced rMF sprouti

245 lement (a key life-history transition) or 10 days post-settlement, and measured a suite of physiologi

246 of time spent foraging over four consecutive days post-settlement.

247 f grouped and solitary fish (n = 14) for 1-4 days post-settlement.

248 At 14 days post-SH, the proportion of animals displaying recov

249 ve ART within 48 h (urgent group) or in 7-14 days (post-stabilisation group) at four hospitals in Ken

250 segments were harvested 1, 3, 7, 14, and 28 days post-stenting for proteomics analysis of the media

251 ascular thrombectomy improves outcomes at 90 days post stroke.

252 at baseline and having AF first diagnosed >7 days post-stroke (late AF) was highly associated with re

253 Rats were killed at 22 days post-stroke and brains extracted for evaluation of

254 IS, determine their temporal course up to 90 days post-stroke, and explore their utility as an early

255 formation and non-leaky blood vessels by 10 days post-stroke.

256 the effect of RRT on ammonia for the first 3 days post study admission (n = 340) and on 21-day TFS (n

257 Seven days post surgery, mice were euthanized, and the stomach

258 gher than control group at 1, 2, 3, 6, and 8 days post-surgery (P <0.001).

259 ene expression analysis was also conducted 2 days post-surgery.

260 on gingival wound healing within the first 2 days post-surgery.

261 BSP-positive cells than control at 10 and 30 days post-surgery.

262 Animals were euthanized at either 10 or 30 days post-surgery.

263 (95% CI, 83.9 to 89.3%) during the first 14 days post-symptom onset (p.s.o.).

264 istinct time periods: periprocedural (0 to 1 days post TAVR); early (2 to 30 days); and late (31 to 7

265 edictive value; CMR performed a median of 40 days post-TAVR had a greater association with post-TAVR

266 atients (2,385 patients with a CVE within 30 days post-TAVR) were analyzed.

267 trast velocity mapping CMR at a median of 40 days post-TAVR, and using Doppler echocardiography at a

268 ng Doppler echocardiography at a median of 6 days post-TAVR.

269 ng perfusion to label the entire cortex at 1 day post TBI followed by whole brain axial and coronal i

270 rformed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks.

271 Nonetheless, 30 days post-TBI a population of deramified and major histo

272 in these signaling pathways was observed 3.5 days post-TBI, when peak crypt regeneration occurs.

273 -GFP and pUB-GFP plasmids and for at least 5 days post-transfection for cells transfected with pEYFP-

274 d cells became NS1-positive approximately 30 days post-transfection in three independent experiments.

275 tion within the D4MT domain approximately 16 days post-transfection in two experiments.

276 conserved NS3 Walker B motif appeared >/=16 days post-transfection.

277 heir blood urea nitrogen was elevated at two days post-transfer but resolved within two weeks.

278 mized trial of GEP versus EMB starting at 55 days post transplant (when GEP is valid).

279 In this pilot study, GEP starting at 55 days post transplant seems comparable with EMB for rejec

280 ion criteria were randomized beginning at 55 days post transplant to either GEP or EMB arms.

281 nsplantation and continuing weekly until 100 days post-transplant, a total of 694 observations in HCT

282 ted with aspartate aminotransferase (AST) 14-day post-transplantation (q < 0.05) and were more abunda

283 Remarkably, 9 days post-transplantation, mice receiving scWAT from exe

284 +/- 1.6% vs. 71.5 +/- 1.8%; P = 0.065) at 30 days post-transplantation.

285 evoid of adverse neurocognitive effects at 7 days post treatment and that slower baseline processing

286 n symptom assessments at 24, 48, 72 h, and 7 days post treatment using the Montgomery-Asberg Depressi

287 lysis and persisted for at least thirty-five days post treatment.

288 bo group was switched to apremilast and a 28-day post-treatment observational follow-up phase.

289 The changes were durable through 28 days post-treatment.

290 Arteries and kidneys were harvested 7 days post-treatment.

291 ific for M. genitalium DNA on samples 14-100 days post-treatment.

292 l; OR 0.56; 95% CI, 0.36-0.88, P = .01 at 14 days post-treatment; 1 trial).

293 ps (OR 0.06; 95% CI, 0.00-0.47, P < .01 at 7 days post-treatment; 1 trial; OR 0.56; 95% CI, 0.36-0.88

294 In the 7 days post vaccination, 60 (94%) of 64 intradermally vacc

295 y of vaccination and CTLA4 and IL2Ralpha two days post-vaccination can classify high and low responde

296 a caused by any strain and occurring from 15 days post-vaccination to the end of the study.

297 Two days post-vaccination, MVA85A induces a strong interfero

298 from the immediate or delayed groups from 6 days post-vaccination.

299 malization in mean HR and QT intervals at 26 days post ventricular amputation (dpa).

300 ies that presented within each sample at 180 days post whole-thorax lung irradiation.